Last reviewed · How we verify
NCT04361630
Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects
EARLY_PHASE1 trial testing FGF 2 in Periodontitis in 30 participants. Completed in 1 December 2019.
1 November 2019
Quick facts
| Lead sponsor | SVS Institute of Dental Sciences |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 May 2019 |
| Primary completion | 1 November 2019 |
| Estimated completion | 1 December 2019 |
| Sites | 1 location across India |
Drugs / interventions tested
- FGF 2
Conditions studied
- Periodontitis — all drugs for Periodontitis →
Sponsor
SVS Institute of Dental Sciences
Who can join
Adults 20 to 45, any sex, with Periodontitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was a single-arm trial to obtain preliminary data on the efficacy of collagen membranes impregnated with recombinant human fibroblast growth factor (rhFGF-2) in the treatment of Miller's class I and class II gingival recessions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04361630
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Periodontitis
Currently open trials in the same condition.
- NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
- NCT07535177 — Gas6 and Soluble MerTK in Periodontal Diseases · recruiting
- NCT07491848 — Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D · recruiting
- NCT07421960 — Investigation of the Relationship Between Periodontitis and Sleep Quality · recruiting
- NCT07532694 — Diode Laser-Assisted Periodontal Therapy in Kidney Transplant Recipients · NA · recruiting
Other SVS Institute of Dental Sciences trials
Trials by the same sponsor.
- NCT04937023 — Ursodeoxycholic Acid (Udca) as a Local Drug Delivery Agent in the Treatment of Intra-bony Defects · NA · unknown
- NCT05342649 — Effect of Two Methods of Soft Tissue Augmentation for Socket Closure on Soft Tissue Landmarks and Ridge Dimensions · NA · completed
- NCT04372420 — Bone Morphogenetic Protein-2 In Grade II Furcation Defects. · NA · completed
- NCT04368650 — RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial · Phase 2 · completed
- NCT03396900 — Periodontally Accelerated Osteogenic Orthodontics With BMP2 · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04361630 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SVS Institute of Dental Sciences
- Last refreshed: 1 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04361630.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing